SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway

Tatsuya Yoshizawa, Md Fazlul Karim, Yoshifumi Sato, Takafumi Senokuchi, Keishi Miyata, Takaichi Fukuda, Chisa Go, Masayoshi Tasaki, Kohei Uchimura, Tsuyoshi Kadomatsu, Zhe Tian, Christian Smolka, Tomohiro Sawa, Motohiro Takeya, Kazuhito Tomizawa, Yukio Ando, Eiichi Araki, Takaaki Akaike, Thomas Braun, Yuichi OikeEva Bober, Kazuya Yamagata

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Sirtuins (SIRT1-7) have attracted considerable attention as regulators of metabolism over the past decade. However, the physiological functions and molecular mechanisms of SIRT7 are poorly understood. Here we demonstrate that Sirt7 knockout mice were resistant to high-fat diet-induced fatty liver, obesity, and glucose intolerance, and that hepatic triglyceride accumulation was also attenuated in liver-specific Sirt7 knockout mice. Hepatic SIRT7 positively regulated the protein level of TR4/TAK1, a nuclear receptor involved in lipid metabolism, and as a consequence activated TR4 target genes to increase fatty acid uptake and triglyceride synthesis/storage. Biochemical studies revealed that the DDB1-CUL4-associated factor 1 (DCAF1)/damage-specific DNA binding protein 1 (DDB1)/cullin 4B (CUL4B) E3 ubiquitin ligase complex interacted with TR4, leading to its degradation, while binding of SIRT7 to the DCAF1/DDB1/CUL4B complex inhibited the degradation of TR4. In conclusion, we propose that hepatic SIRT7 controls lipid metabolism in liver by regulating the ubiquitin-proteasome pathway.

Original languageEnglish
Pages (from-to)712-721
Number of pages10
JournalCell Metabolism
Volume19
Issue number4
DOIs
Publication statusPublished - Apr 1 2014
Externally publishedYes

Fingerprint

Proteasome Endopeptidase Complex
Ubiquitin
Lipid Metabolism
DNA-Binding Proteins
Liver
Knockout Mice
Triglycerides
Sirtuins
Ubiquitin-Protein Ligases
Glucose Intolerance
High Fat Diet
Fatty Liver
Cytoplasmic and Nuclear Receptors
Fatty Acids
Obesity
Genes
Proteins
Cullin 1

ASJC Scopus subject areas

  • Physiology
  • Molecular Biology
  • Cell Biology

Cite this

Yoshizawa, T., Karim, M. F., Sato, Y., Senokuchi, T., Miyata, K., Fukuda, T., ... Yamagata, K. (2014). SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway. Cell Metabolism, 19(4), 712-721. https://doi.org/10.1016/j.cmet.2014.03.006

SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway. / Yoshizawa, Tatsuya; Karim, Md Fazlul; Sato, Yoshifumi; Senokuchi, Takafumi; Miyata, Keishi; Fukuda, Takaichi; Go, Chisa; Tasaki, Masayoshi; Uchimura, Kohei; Kadomatsu, Tsuyoshi; Tian, Zhe; Smolka, Christian; Sawa, Tomohiro; Takeya, Motohiro; Tomizawa, Kazuhito; Ando, Yukio; Araki, Eiichi; Akaike, Takaaki; Braun, Thomas; Oike, Yuichi; Bober, Eva; Yamagata, Kazuya.

In: Cell Metabolism, Vol. 19, No. 4, 01.04.2014, p. 712-721.

Research output: Contribution to journalArticle

Yoshizawa, T, Karim, MF, Sato, Y, Senokuchi, T, Miyata, K, Fukuda, T, Go, C, Tasaki, M, Uchimura, K, Kadomatsu, T, Tian, Z, Smolka, C, Sawa, T, Takeya, M, Tomizawa, K, Ando, Y, Araki, E, Akaike, T, Braun, T, Oike, Y, Bober, E & Yamagata, K 2014, 'SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway', Cell Metabolism, vol. 19, no. 4, pp. 712-721. https://doi.org/10.1016/j.cmet.2014.03.006
Yoshizawa T, Karim MF, Sato Y, Senokuchi T, Miyata K, Fukuda T et al. SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway. Cell Metabolism. 2014 Apr 1;19(4):712-721. https://doi.org/10.1016/j.cmet.2014.03.006
Yoshizawa, Tatsuya ; Karim, Md Fazlul ; Sato, Yoshifumi ; Senokuchi, Takafumi ; Miyata, Keishi ; Fukuda, Takaichi ; Go, Chisa ; Tasaki, Masayoshi ; Uchimura, Kohei ; Kadomatsu, Tsuyoshi ; Tian, Zhe ; Smolka, Christian ; Sawa, Tomohiro ; Takeya, Motohiro ; Tomizawa, Kazuhito ; Ando, Yukio ; Araki, Eiichi ; Akaike, Takaaki ; Braun, Thomas ; Oike, Yuichi ; Bober, Eva ; Yamagata, Kazuya. / SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway. In: Cell Metabolism. 2014 ; Vol. 19, No. 4. pp. 712-721.
@article{199bfbe22ddb481eae93164b1e2a79ac,
title = "SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway",
abstract = "Sirtuins (SIRT1-7) have attracted considerable attention as regulators of metabolism over the past decade. However, the physiological functions and molecular mechanisms of SIRT7 are poorly understood. Here we demonstrate that Sirt7 knockout mice were resistant to high-fat diet-induced fatty liver, obesity, and glucose intolerance, and that hepatic triglyceride accumulation was also attenuated in liver-specific Sirt7 knockout mice. Hepatic SIRT7 positively regulated the protein level of TR4/TAK1, a nuclear receptor involved in lipid metabolism, and as a consequence activated TR4 target genes to increase fatty acid uptake and triglyceride synthesis/storage. Biochemical studies revealed that the DDB1-CUL4-associated factor 1 (DCAF1)/damage-specific DNA binding protein 1 (DDB1)/cullin 4B (CUL4B) E3 ubiquitin ligase complex interacted with TR4, leading to its degradation, while binding of SIRT7 to the DCAF1/DDB1/CUL4B complex inhibited the degradation of TR4. In conclusion, we propose that hepatic SIRT7 controls lipid metabolism in liver by regulating the ubiquitin-proteasome pathway.",
author = "Tatsuya Yoshizawa and Karim, {Md Fazlul} and Yoshifumi Sato and Takafumi Senokuchi and Keishi Miyata and Takaichi Fukuda and Chisa Go and Masayoshi Tasaki and Kohei Uchimura and Tsuyoshi Kadomatsu and Zhe Tian and Christian Smolka and Tomohiro Sawa and Motohiro Takeya and Kazuhito Tomizawa and Yukio Ando and Eiichi Araki and Takaaki Akaike and Thomas Braun and Yuichi Oike and Eva Bober and Kazuya Yamagata",
year = "2014",
month = "4",
day = "1",
doi = "10.1016/j.cmet.2014.03.006",
language = "English",
volume = "19",
pages = "712--721",
journal = "Cell Metabolism",
issn = "1550-4131",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway

AU - Yoshizawa, Tatsuya

AU - Karim, Md Fazlul

AU - Sato, Yoshifumi

AU - Senokuchi, Takafumi

AU - Miyata, Keishi

AU - Fukuda, Takaichi

AU - Go, Chisa

AU - Tasaki, Masayoshi

AU - Uchimura, Kohei

AU - Kadomatsu, Tsuyoshi

AU - Tian, Zhe

AU - Smolka, Christian

AU - Sawa, Tomohiro

AU - Takeya, Motohiro

AU - Tomizawa, Kazuhito

AU - Ando, Yukio

AU - Araki, Eiichi

AU - Akaike, Takaaki

AU - Braun, Thomas

AU - Oike, Yuichi

AU - Bober, Eva

AU - Yamagata, Kazuya

PY - 2014/4/1

Y1 - 2014/4/1

N2 - Sirtuins (SIRT1-7) have attracted considerable attention as regulators of metabolism over the past decade. However, the physiological functions and molecular mechanisms of SIRT7 are poorly understood. Here we demonstrate that Sirt7 knockout mice were resistant to high-fat diet-induced fatty liver, obesity, and glucose intolerance, and that hepatic triglyceride accumulation was also attenuated in liver-specific Sirt7 knockout mice. Hepatic SIRT7 positively regulated the protein level of TR4/TAK1, a nuclear receptor involved in lipid metabolism, and as a consequence activated TR4 target genes to increase fatty acid uptake and triglyceride synthesis/storage. Biochemical studies revealed that the DDB1-CUL4-associated factor 1 (DCAF1)/damage-specific DNA binding protein 1 (DDB1)/cullin 4B (CUL4B) E3 ubiquitin ligase complex interacted with TR4, leading to its degradation, while binding of SIRT7 to the DCAF1/DDB1/CUL4B complex inhibited the degradation of TR4. In conclusion, we propose that hepatic SIRT7 controls lipid metabolism in liver by regulating the ubiquitin-proteasome pathway.

AB - Sirtuins (SIRT1-7) have attracted considerable attention as regulators of metabolism over the past decade. However, the physiological functions and molecular mechanisms of SIRT7 are poorly understood. Here we demonstrate that Sirt7 knockout mice were resistant to high-fat diet-induced fatty liver, obesity, and glucose intolerance, and that hepatic triglyceride accumulation was also attenuated in liver-specific Sirt7 knockout mice. Hepatic SIRT7 positively regulated the protein level of TR4/TAK1, a nuclear receptor involved in lipid metabolism, and as a consequence activated TR4 target genes to increase fatty acid uptake and triglyceride synthesis/storage. Biochemical studies revealed that the DDB1-CUL4-associated factor 1 (DCAF1)/damage-specific DNA binding protein 1 (DDB1)/cullin 4B (CUL4B) E3 ubiquitin ligase complex interacted with TR4, leading to its degradation, while binding of SIRT7 to the DCAF1/DDB1/CUL4B complex inhibited the degradation of TR4. In conclusion, we propose that hepatic SIRT7 controls lipid metabolism in liver by regulating the ubiquitin-proteasome pathway.

UR - http://www.scopus.com/inward/record.url?scp=84897484512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897484512&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2014.03.006

DO - 10.1016/j.cmet.2014.03.006

M3 - Article

C2 - 24703702

AN - SCOPUS:84897484512

VL - 19

SP - 712

EP - 721

JO - Cell Metabolism

JF - Cell Metabolism

SN - 1550-4131

IS - 4

ER -